#purdue-pharma

[ follow ]

Federal Circuit Affirms Invalidity of Purdue's OxyContin Patents

The Federal Circuit affirmed the invalidity of Purdue Pharma's OxyContin patents due to obviousness, impacting patent law standards.
The ruling highlights the importance of analyzing inherent properties and known problems in patent obviousness evaluations.
#mckinsey

McKinsey & Company to pay $650 million for role in opioid crisis

McKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.

McKinsey to pay $650m to resolve US investigation into opioid crisis role

McKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.

McKinsey & Company to pay $650 million for role in opioid crisis

McKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.

McKinsey to pay $650m to resolve US investigation into opioid crisis role

McKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.
moremckinsey
#mckinsey--company

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.

McKinsey to pay $650m to settle US opioid consulting probe

McKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

McKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.

McKinsey to pay $650m to settle US opioid consulting probe

McKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

McKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.
moremckinsey--company
#opioid-crisis

Supreme Court Blocks Nationwide Opioid Settlement

The Supreme Court rejected a multi-billion dollar settlement with Purdue Pharma, allowing lawsuits affecting the opioid crisis to continue.

Harvard University will not rename its Arthur M. Sackler Museum

Harvard University decided not to rename Arthur M. Sackler Museum despite ties to opioid crisis.

States and Creditors for Purdue Pharma Threaten Sacklers With Gush of Lawsuits

Legal actions being prepared against the Sackler family for their role in the opioid crisis despite denied legal immunity.

Supreme Court Blocks Nationwide Opioid Settlement

The Supreme Court rejected a multi-billion dollar settlement with Purdue Pharma, allowing lawsuits affecting the opioid crisis to continue.

Harvard University will not rename its Arthur M. Sackler Museum

Harvard University decided not to rename Arthur M. Sackler Museum despite ties to opioid crisis.

States and Creditors for Purdue Pharma Threaten Sacklers With Gush of Lawsuits

Legal actions being prepared against the Sackler family for their role in the opioid crisis despite denied legal immunity.
moreopioid-crisis

Money for California's Opioid Fight in Limbo After US Supreme Court Ruling | KQED

Negotiations in Purdue Pharma case could potentially lead to bankruptcy for Sackler family, impacting how funds will be distributed among plaintiffs.

Purdue Opioid Settlement on Verge of Collapse After Supreme Court Ruling

The Supreme Court rejected liability protections for Purdue Pharma's owners, jeopardizing the settlement and release of funds crucial for combating opioid addiction.
#opioid-epidemic

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

Supreme Court Rejects Liability Shield at Center of Purdue Pharma Settlement

The Supreme Court rejected a provision shielding the Sackler family in the Purdue Pharma settlement, impacting the distribution of funds to address the opioid epidemic.

The Supreme Court Rejects a Nationwide Opioid Settlement With OxyContin Maker Purdue Pharma

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo | CBC News

The U.S. Supreme Court rejected a nationwide settlement with Purdue Pharma, blocking the shield for the Sackler family and billions to combat opioids.

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

Supreme Court Rejects Liability Shield at Center of Purdue Pharma Settlement

The Supreme Court rejected a provision shielding the Sackler family in the Purdue Pharma settlement, impacting the distribution of funds to address the opioid epidemic.

The Supreme Court Rejects a Nationwide Opioid Settlement With OxyContin Maker Purdue Pharma

The Supreme Court rejected a nationwide settlement with Purdue Pharma, impacting the Sackler family and victims of the opioid epidemic.

U.S. Supreme Court decision rejects Purdue Pharma opioid settlement, leaving victims in limbo | CBC News

The U.S. Supreme Court rejected a nationwide settlement with Purdue Pharma, blocking the shield for the Sackler family and billions to combat opioids.
moreopioid-epidemic
[ Load more ]